Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioglan Medlab is a specialized practitioner-only nutraceutical brand owned by PharmaCare Laboratories, a prominent Australian health and wellness company. The brand was established following PharmaCare's 2021 acquisition of the nutraceutical business and Medlab trademark from Medlab Clinical Ltd. Bioglan Medlab focuses on delivering high-quality, evidence-based supplements that utilize the proprietary NanoCelle delivery platform, a sub-micron spray technology designed to improve bioavailability. The product portfolio addresses a wide range of clinical needs, including musculoskeletal health, gastrointestinal support, and metabolic wellness. Distributed exclusively through healthcare professionals, the brand bridges the gap between traditional supplements and pharmaceutical delivery standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioglan Medlab.